Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products

Detalhes bibliográficos
Autor(a) principal: Marco, Bianca A. de [UNESP]
Data de Publicação: 2020
Outros Autores: Maggio, Ruben M., Nunes Salgado, Herida R. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1007/s40005-020-00470-3
http://hdl.handle.net/11449/208776
Resumo: Purpose The presence of different polymorphic or pseudo-polymorphic forms in active pharmaceutical ingredients may affect the performance of the formulated products. Pseudo-polymorphs, especially hydrates, present a differential dissolution rate. In such a scenario, pseudo-polymorphism should be strictly controlled due to its impact on the bio-availability of formulates products. Methods In order to determine solid forms of cefadroxil present in commercial capsules, anhydrous and monohydrate pure the solid forms were prepared and fully characterized by optical microscopy, vibrational spectroscopy (middle and near infrared), calorimetric techniques (differential scanning calorimetry and thermogravimetry). Nuclear magnetic resonance was used to corroborate structural integrity. Two sets of synthetic samples for calibration (N = 12) and validation (N = 12) were prepared following a binary-mixtures design of monohydrate/anhydrous cefadroxil in the presence of the excipient matrix. NIR spectra were acquired and used as input of partial least squares (PLS) model. Results Three PLS-factors, mean scattering correction and MIN-MAX normalization demonstrated to be the optimal parameters on full range spectra (750-2500 nm). The method was validated for linearity/range, accuracy and precision by evaluation of validation set recovery. Once method validated, a commercial lot of capsules was analyzed and acceptable recovery results and low deviations were obtained. Conclusion Near infrared spectroscopy (NIR) emerged as the technique of choice to determine pseudopolymorphic-purity. Cefadroxil monohydrate was determined in a fast and accurate way in presentence of cefadroxil anhydrous and excipients by NIR-PLS methodology. The developed analytical methodology, arise as a general strategy for hydrates determination, making a direct determination of pseudopolymorphic form.
id UNSP_91765f83ae62bcd3158cdd73a3a227b5
oai_identifier_str oai:repositorio.unesp.br:11449/208776
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial productsPseudo-polymorphismHydratesNIRChemometricsCefadroxilPurpose The presence of different polymorphic or pseudo-polymorphic forms in active pharmaceutical ingredients may affect the performance of the formulated products. Pseudo-polymorphs, especially hydrates, present a differential dissolution rate. In such a scenario, pseudo-polymorphism should be strictly controlled due to its impact on the bio-availability of formulates products. Methods In order to determine solid forms of cefadroxil present in commercial capsules, anhydrous and monohydrate pure the solid forms were prepared and fully characterized by optical microscopy, vibrational spectroscopy (middle and near infrared), calorimetric techniques (differential scanning calorimetry and thermogravimetry). Nuclear magnetic resonance was used to corroborate structural integrity. Two sets of synthetic samples for calibration (N = 12) and validation (N = 12) were prepared following a binary-mixtures design of monohydrate/anhydrous cefadroxil in the presence of the excipient matrix. NIR spectra were acquired and used as input of partial least squares (PLS) model. Results Three PLS-factors, mean scattering correction and MIN-MAX normalization demonstrated to be the optimal parameters on full range spectra (750-2500 nm). The method was validated for linearity/range, accuracy and precision by evaluation of validation set recovery. Once method validated, a commercial lot of capsules was analyzed and acceptable recovery results and low deviations were obtained. Conclusion Near infrared spectroscopy (NIR) emerged as the technique of choice to determine pseudopolymorphic-purity. Cefadroxil monohydrate was determined in a fast and accurate way in presentence of cefadroxil anhydrous and excipients by NIR-PLS methodology. The developed analytical methodology, arise as a general strategy for hydrates determination, making a direct determination of pseudopolymorphic form.Secretaria de Ciencia y Tecnologia de la UNR (SECyT-UNR)Sao Paulo State Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Araraquara, SP, BrazilUniv Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Anal Med, Suipacha 531,S2002LRK, Rosario, Santa Fe, ArgentinaUNR, CONICET, Inst Quim Rosario, Suipacha 531,S2002LRK, Rosario, Santa Fe, ArgentinaSao Paulo State Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Araraquara, SP, BrazilSecretaria de Ciencia y Tecnologia de la UNR (SECyT-UNR): BIO498Secretaria de Ciencia y Tecnologia de la UNR (SECyT-UNR): BIO572SpringerUniversidade Estadual Paulista (Unesp)Univ Nacl RosarioUNRMarco, Bianca A. de [UNESP]Maggio, Ruben M.Nunes Salgado, Herida R. [UNESP]2021-06-25T11:20:16Z2021-06-25T11:20:16Z2020-01-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article425-433http://dx.doi.org/10.1007/s40005-020-00470-3Journal Of Pharmaceutical Investigation. London: Springernature, v. 50, n. 4, p. 425-433, 2020.2093-5552http://hdl.handle.net/11449/20877610.1007/s40005-020-00470-3WOS:000510276800001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal Of Pharmaceutical Investigationinfo:eu-repo/semantics/openAccess2021-10-23T19:02:29Zoai:repositorio.unesp.br:11449/208776Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:07:20.892094Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
title Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
spellingShingle Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
Marco, Bianca A. de [UNESP]
Pseudo-polymorphism
Hydrates
NIR
Chemometrics
Cefadroxil
title_short Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
title_full Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
title_fullStr Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
title_full_unstemmed Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
title_sort Development of a general strategy for the quantification of pseudopolymorphs: analysis of cefadroxil monohydrate in commercial products
author Marco, Bianca A. de [UNESP]
author_facet Marco, Bianca A. de [UNESP]
Maggio, Ruben M.
Nunes Salgado, Herida R. [UNESP]
author_role author
author2 Maggio, Ruben M.
Nunes Salgado, Herida R. [UNESP]
author2_role author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Univ Nacl Rosario
UNR
dc.contributor.author.fl_str_mv Marco, Bianca A. de [UNESP]
Maggio, Ruben M.
Nunes Salgado, Herida R. [UNESP]
dc.subject.por.fl_str_mv Pseudo-polymorphism
Hydrates
NIR
Chemometrics
Cefadroxil
topic Pseudo-polymorphism
Hydrates
NIR
Chemometrics
Cefadroxil
description Purpose The presence of different polymorphic or pseudo-polymorphic forms in active pharmaceutical ingredients may affect the performance of the formulated products. Pseudo-polymorphs, especially hydrates, present a differential dissolution rate. In such a scenario, pseudo-polymorphism should be strictly controlled due to its impact on the bio-availability of formulates products. Methods In order to determine solid forms of cefadroxil present in commercial capsules, anhydrous and monohydrate pure the solid forms were prepared and fully characterized by optical microscopy, vibrational spectroscopy (middle and near infrared), calorimetric techniques (differential scanning calorimetry and thermogravimetry). Nuclear magnetic resonance was used to corroborate structural integrity. Two sets of synthetic samples for calibration (N = 12) and validation (N = 12) were prepared following a binary-mixtures design of monohydrate/anhydrous cefadroxil in the presence of the excipient matrix. NIR spectra were acquired and used as input of partial least squares (PLS) model. Results Three PLS-factors, mean scattering correction and MIN-MAX normalization demonstrated to be the optimal parameters on full range spectra (750-2500 nm). The method was validated for linearity/range, accuracy and precision by evaluation of validation set recovery. Once method validated, a commercial lot of capsules was analyzed and acceptable recovery results and low deviations were obtained. Conclusion Near infrared spectroscopy (NIR) emerged as the technique of choice to determine pseudopolymorphic-purity. Cefadroxil monohydrate was determined in a fast and accurate way in presentence of cefadroxil anhydrous and excipients by NIR-PLS methodology. The developed analytical methodology, arise as a general strategy for hydrates determination, making a direct determination of pseudopolymorphic form.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-30
2021-06-25T11:20:16Z
2021-06-25T11:20:16Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1007/s40005-020-00470-3
Journal Of Pharmaceutical Investigation. London: Springernature, v. 50, n. 4, p. 425-433, 2020.
2093-5552
http://hdl.handle.net/11449/208776
10.1007/s40005-020-00470-3
WOS:000510276800001
url http://dx.doi.org/10.1007/s40005-020-00470-3
http://hdl.handle.net/11449/208776
identifier_str_mv Journal Of Pharmaceutical Investigation. London: Springernature, v. 50, n. 4, p. 425-433, 2020.
2093-5552
10.1007/s40005-020-00470-3
WOS:000510276800001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Journal Of Pharmaceutical Investigation
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 425-433
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128318279516160